The gap between trailing P/E of 39.89 and forward P/E of 22.41 suggests analysts anticipate a meaningful earnings recovery, which is consistent with the volatile quarterly operating margins in the data. A PEG of 2.68 indicates the market is paying a premium relative to the growth rate embedded in those estimates, so the valuation is less defensible if margin recovery stalls. Relative to peers such as BSX at 23.01x and MDT at 28.11x, SYK screens expensive on trailing earnings, although its forward multiple sits closer to the group, warranting investor attention to whether the implied earnings path materializes.

Gross margin stayed in a relatively narrow 61% to 68% band, which points to stable product economics, so the operating margin volatility appears driven by below-gross-profit cost behavior rather than pricing. Net margin of 11.5% in 2026Q3 sits well below the 15% to 19% levels of mid-2024 and 2026Q2, suggesting non-operating or tax items may be contributing to the decline. Investors should monitor whether operating leverage improves, since the current spread limits confidence in forward margin assumptions.

ROE has trended in a narrow 2.7% to 5.4% range, and the low ROA of roughly 1.5% to 2.7% reflects a large capital base relative to earnings, consistent with the goodwill-heavy balance sheet. Returns this low suggest the acquisition-driven asset base is not yet generating returns that justify its carrying value. The persistence of these modest returns is a central question for whether the franchise is compounding capital or merely maintaining it.

The decline in D/E alongside rising interest coverage suggests the company is absorbing acquisition debt without strain, though debt-to-EBITDA near 11.6x in 2026Q3 remains elevated and warrants monitoring. Because the coverage ratio is calculated on quarterly EBITDA, a weaker margin quarter could compress it quickly. Refinancing exposure cannot be assessed from the supplied data, so this read reflects reported figures rather than a full maturity profile.